Analyst Reco. Merck & Co., Inc.

Equities

MRK

US58933Y1055

Market Closed - Nyse Other stock markets 16:00:02 2024-09-11 EDT			5-day change	1st Jan Change
114.71 ^USD	-0.54%		-0.94%	+5.22%

09-11	Merck: positive results for HPV vaccine	CF
09-11	Merck's HPV Vaccine Meets Main Goal in Phase 3 Study in Japanese Males	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Citic Securities Initiates Merck & Co. at Buy With $136 Price Target	08-29	MT
Jefferies Adjusts Merck & Company Price Target to $147 From $150	08-15	MT
Deutsche Bank Adjusts Price Target on Merck to $145 From $140	08-08	MT
Berenberg Adjusts Price Target on Merck & Co. to $135 From $143, Maintains Buy Rating	08-08	MT
Daiwa Securities Adjusts Merck & Company Price Target to $130 From $150, Maintains Outperform Rating	08-06	MT
UBS Adjusts Merck & Co.'s Price Target to $142 From $148, Maintains Buy Rating	07-31	MT
Morgan Stanley Adjusts Price Target on Merck & Company to $130 From $134	07-31	MT
Goldman Sachs Adjusts Price Target on Merck & Company to $140 From $145, Maintains Buy Rating	07-31	MT
Guggenheim Adjusts Price Target on Merck & Company to $138 From $142, Maintains Buy Rating	07-31	MT
Wolfe Research Adjusts Price Target on Merck & Co. to $142 From $151, Maintains Outperform Rating	07-31	MT
Barclays Adjusts Price Target on Merck & Co. to $142 From $145, Maintains Overweight Rating	07-31	MT
Wells Fargo Adjusts Price Target on Merck & Co. to $125 From $140, Maintains Equalweight Rating	07-31	MT
BMO Capital Adjusts Price Target on Merck to $150 From $148	07-19	MT
TD Cowen Adjusts Price Target on Merck to $140 From $135	07-17	MT
Goldman Sachs Adjusts Price Target on Merck & Company to $145 From $144	07-16	MT
Morgan Stanley Adjusts Price Target on Merck to $134 From $132	07-11	MT
HSBC Adjusts Price Target on Merck & Co. to $130 From $118, Keeps Hold Rating	06-05	MT
Analyst recommendations: Boeing, Dell, Merck, RyanAir...	05-27
Redburn Atlantic Adjusts Price Target on Merck to $148 From $142	05-01	MT
Wolfe Research Adjusts Price Target on Merck & Company to $151 From $141	04-26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Merck & Co., Inc.

Equities

MRK

US58933Y1055

Analyst Reco.

Filters